AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2,169 Cr |
| Mar2024 | ₹-1,021 Cr |
| Mar2023 | ₹223 Cr |
| Mar2022 | ₹-1,164 Cr |
| Mar2021 | ₹2,563 Cr |
How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,169 Cr | Positive | |
| Mar2024 | ₹-1,021 Cr | Negative | |
| Mar2023 | ₹223 Cr | Positive | |
| Mar2022 | ₹-1,164 Cr | Negative | |
| Mar2021 | ₹2,563 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹93,220.6 Cr | 4.6% | 12.5% | 38.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 4.6% |
12.5% |
38.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses